Craves Fred (Director) plans to sell 22,489 MDGL shares, about $4.8M
- Form
- 144
- Filed
- Importance
- Routine
- Accession
- 0001950047-24-003660
- Document
- Form 144
- Approximate sale date: May 14, 2024
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Shares acquired by: Exercise of Stock Options
- 10b5-1 plan adopted: Dec 15, 2023
All of Craves Fred's insider filings, holdings and planned sales
Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):
- Sold 8,827 shares at $210.99 on May 14, 2024 · Form 4
- Sold 5,009 shares at $211.84 on May 14, 2024 · Form 4
- Sold 1,363 shares at $212.85 on May 14, 2024 · Form 4
- Sold 2,190 shares at $213.85 on May 14, 2024 · Form 4
- Sold 1,804 shares at $214.68 on May 14, 2024 · Form 4
- Sold 375 shares at $216.08 on May 14, 2024 · Form 4
- Sold 721 shares at $216.98 on May 14, 2024 · Form 4
- Sold 1,100 shares at $217.86 on May 14, 2024 · Form 4
- Sold 1,000 shares at $218.99 on May 14, 2024 · Form 4
- Sold 100 shares at $219.9 on May 14, 2024 · Form 4
Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Ionis Pharmaceuticals IONS public float $5.3B, Jun 30, 2025
- Repligen RGEN public float $6.0B, Jun 30, 2025
- Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
- Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
- Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025